Navigation Links
Aptima in Medical News

Gen-Probe Reports Financial Results for Second Quarter 2009

...plant diagnostics and genetic testing products, and continued growth of the aptima Combo 2(R) assay, an amplified nucleic acid test (NAT) for simultaneously d... information, go to www.gen-probe.com. Trademarks APTIMA, aptima COMBO 2, PACE, PROGENSA and TIGRIS are trademarks of Gen-Probe Incorporated...

Gen-Probe Reports Financial Results for First Quarter 2009

...ter of 2009 benefited from continued growth of the aptima Combo 2(R) assay, an amplified nucleic acid test (...ngoing European market development efforts for the aptima Combo 2, aptima HPV and PROGENSA(TM) PCA3 assays. General a...

Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement

...t and general counsel. "We continue to expect our aptima HPV assay, which is available in Europe and is in ...oncerning future development, the potential of the aptima HPV assay, and reimbursement of legal expenses are...e may not successfully complete development of our aptima HPV assay, (ii) the risk that the HPV market will ...

Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008

...rter of 2008 reflected the continued growth of the aptima Combo 2(R) assay, an amplified nucleic acid test (...IO assay in the United States, the investigational aptima human papillomavirus (HPV) assay, and Gen-Probe's ...arket development efforts related to the Company's aptima Combo 2,...

Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance

...ter of 2008 benefited from continued growth of the aptima Combo 2(R) assay, an amplified nucleic acid test (...IO assay in the United States, the investigational aptima human papillomavirus (HPV) assay, and Gen-Probe's ...arket development efforts related to the Company's aptima Combo 2,...
Aptima in Medical Technology

Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer

...ly result in the introduction of a highly accurate aptima HPV assay that improves the detection and treatment of cervical cancer." The investigational aptima HPV assay is an amplified nucleic acid test that d...re normal. This arm will assess the ability of the aptima HPV test to identify women who are at greater risk...
Aptima in Medical Products

Aptima Combo 2® Assay

Description:... The aptima COMBO 2 Assay is a second generation nucleic acid amplification test that uses target capture for in vitro qualitative detection and differentiation o...
Company:Gen-Probe
Aptima in Biological Technology

Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting

...sia (EUROGIN) in Nice, France. Gen-Probe's aptima HPV assay has been CE-marked for sale in the Europ... "As a whole, these studies suggest that our new aptima HPV assay may detect high-risk HPV infections that... director, presented interim results of the French aptima HPV Screening Evaluation (FASE) study from 1,528 w...

Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus

...lomavirus (HPV), which causes cervical cancer. The aptima HPV Assay has been CE marked and is currently avai...ion countries. "The CE marking and launch of our aptima HPV Assay in Europe reflect Gen-Probe's commitment... and future automated instrument platforms." The aptima HPV Assay is an amplified nucleic acid test that d...

Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance

...ter of 2008 benefited from continued growth of the aptima Combo 2(R) assay, an amplified nucleic acid test (...ent resulted primarily from increased sales of the aptima Combo 2 assay and from commercial pricing of the P...arket development efforts related to the Company's aptima HPV and PROGENSATM PCA3 assays. General and admi...

Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007

...n the fourth quarter of 2007 were again led by the aptima Combo 2(R) assay, an amplified nucleic acid test (...t efforts related to the Company's investigational aptima HPV assay. For the full year 2007, marketing and s...e led by continued market share gains for the aptima Combo 2 assay, by commercial pricing of the P...

Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues

...in the third quarter of 2007 were again led by the aptima Combo 2(R) assay, an amplified nucleic acid test (...o http://www.gen-probe.com . Trademarks APTIMA, aptima COMBO 2, PACE and TIGRIS are trademarks of Gen-Pro...le of our new products, such as our TIGRIS system, aptima Combo 2 assay, PROCLEIX ULTRIO assay and PROGENSA ...
Other Tags
(Date:7/11/2014)... 11, 2014 Los Angeles dental ... he uses mini and full mouth implants to replace ... feature that distinguishes dental implants from other tooth replacements: ... the crowns. This alone prevents the long-term complications of ... advantages related to comfort, appearance and systemic health. Mini ...
(Date:7/11/2014)... Maureen Salamon HealthDay Reporter ... the millions of women who can,t cough, sneeze or ... treatment that uses stem cells to regenerate weakened urethra ... found that injecting stem cells isolated from patients, own ... participants within a year. Stress incontinence affects ...
(Date:7/11/2014)... 11, 2014 Recent research findings regarding Fourth ... atmosphere, and how water affects human bodies. That was the ... during an interview on the Sharon Kleyne Hour Power of ... , Gerald Pollack, PhD, is a Professor of Bioengineering at ... Phase of Water (Ebner & Sons, 2013). , ...
(Date:7/11/2014)... WA (PRWEB) July 11, 2014 Shoulder ... the rate of return to play has not been ... the American Orthopaedic Society for Sports Medicine’s ( AOSSM ... NFL players is approximately 90 percent no matter what ... highlighted the success rate of return to play following ...
(Date:7/11/2014)... (ACL) reconstructions occur more than 200,000 times a year, ... new ligament may determine how long you stay in ... the Annual Meeting of the American Orthopaedic Society of ... highlight that in a young athletic population, allografts (tissue ... autografts (tissue harvested from the patient)," said Craig R. ...
Breaking Medicine News(10 mins):Health News:Dental Implant Dentist, Kevin Sands DDS, Now Uses Mini and Full Mouth Implants to Replace Missing Teeth 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 3Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 2Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 3Health News:Stabilizing Shoulder Surgery Helps NFL Players Return to the Game 2Health News:ACL reconstructions may last longer with autografts 2
(Date:7/11/2014)... 11, 2014 Research and Markets ... Technology Market - Industry Analysis Size Share Growth Trends ... http://photos.prnewswire.com/prnh/20130307/600769 ... created a need for high level security in both ... authentication such as username and passwords, tokens etc. are ...
(Date:7/10/2014)... other major cities in New Mexico, nearly every public ... rather than precious potable water supplies. Across the U.S. ... golf courses receive treated effluent. Reusing the effluent increases ... courses and homeowners alike fertilize their lawns during the ... A New Mexico State University turfgrass expert has a ...
(Date:7/10/2014)...  Aware, Inc. (NASDAQ: AWRE ), a ... on June 26, 2014 that its Board of Directors ... share, or approximately $40 million in total.  The Board ... a payment date of July 24, 2014.  The Company ... an ex-dividend date for this special cash dividend.  An ...
Breaking Biology News(10 mins):International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2'Tailored' water -- the latest in lawn care 2NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2
Other Contents